Clinical study of nibentan - New class III antiarrhythmic drug. II. Efficacy in patients with supraventricular arrhythmias

Kardiologiya

Volumn 36, Issue 6, 1996, Pages 28-37

  Ruda, M Ya ^a   Merkulova, I N ^a   Tararak, A E ^a   Dragnev, A G ^a   Golitsin, S P ^a   Rosenshtraukh, L V ^a   Chazov, E I ^a  

^a NONE

Author keywords

III antiarrhythmic drugs; Nibeman; Supraventricular arrhythmias

Indexed keywords

EID: 1842264139     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Antman E.M., Friedman P.L. Long-term oral propafenone therapy for supression of refractory symptomatic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1988;12:1005-1111.
2. Bertini G., Fradella G. Propafenone versus amiodarone in field treatment of primary atrial tachydysarrhythmias. J Emergency Med 1990;15:698-707.
3. Bialy D., Meissner M.D. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 1992;19:41 (abstr.).
4. Borgreffe M., Breithardt G. Electrophysiologic effect of sotalol in supraventricular tachycardia. Z Kardiol 1985;74:506-511.
5. Camm A.J., Vince Paul. Sotalol for supraventricular tachycardias. Am J Cardiol 1990;2:67A-73A.
6. Campbell T.J., Morgan J.H. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Br Heart J 1985;54:86-90.
7. Cockrell J. et al. Safety and efficacy of intravenous sotalol in terminating supraventricular tachyarrhythmias. J Am Col Cardiol 1991:17:56A.
8. Coplen S.E., Antman E.M., Berlin J.A. et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials. Circulation 1990;82:1106-1116.
9. Cowan J.C., Reid D.S. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating acute myocardial infarction. J Cardiovasc Pharmacol 1986;8:252-256.
10. De Marco J.P. Cardioconversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agent. J Am Coll Cardiol 1991;17:234A.
11. Falk R.H. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 1989;111:107-111.